OTR Therapeutics Raises USD 100 Million to Advance Transformative Therapies
OTR Therapeutics has secured USD 100 million in Series A funding to accelerate the development of its pipeline of differentiated therapies aimed at addressing major unmet needs across immunology, inflammation, oncology, and other disease areas.
OTR Therapeutics | 05/12/2025 | By Dineshwori | 139
Bayer Launches Bayer Co.Lab AdVenture Platform in China
Bayer launches Co.Lab AdVenture to connect biotech startups with global VCs, accelerating early-stage innovation through its lifesciences incubator network.
OTR Therapeutics | 11/09/2025 | By Dineshwori | 148
Bayer Expands Global Life Sciences Incubator With Launch Of Co.Lab AdVenture
Bayer has launched Co.Lab AdVenture, a new platform under its global life sciences incubator network, designed to connect high-potential biotech start-ups with leading venture capital partners worldwide.
OTR Therapeutics | 09/09/2025 | By Darshana | 220
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy